208 related articles for article (PubMed ID: 38122911)
1. Clinical pharmacokinetic evaluation of Withania somnifera (L.) Dunal root extract in healthy human volunteers: A non-randomized, single dose study utilizing UHPLC-MS/MS analysis.
Vaidya VG; Naik NN; Ganu G; Parmar V; Jagtap S; Saste G; Bhatt A; Mulay V; Girme A; Modi SJ; Hingorani L
J Ethnopharmacol; 2024 Mar; 322():117603. PubMed ID: 38122911
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic Study of Withanosides and Withanolides from
Modi SJ; Tiwari A; Ghule C; Pawar S; Saste G; Jagtap S; Singh R; Deshmukh A; Girme A; Hingorani L
Molecules; 2022 Feb; 27(5):. PubMed ID: 35268576
[No Abstract] [Full Text] [Related]
3. Clinical safety and tolerability evaluation of Withania somnifera (L.) Dunal (Ashwagandha) root extract in healthy human volunteers.
Vaidya VG; Gothwad A; Ganu G; Girme A; Modi SJ; Hingorani L
J Ayurveda Integr Med; 2024; 15(1):100859. PubMed ID: 38154316
[TBL] [Abstract][Full Text] [Related]
4. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.
Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK
J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987
[TBL] [Abstract][Full Text] [Related]
5. Investigating 11 Withanosides and Withanolides by UHPLC-PDA and Mass Fragmentation Studies from Ashwagandha (
Girme A; Saste G; Pawar S; Balasubramaniam AK; Musande K; Darji B; Satti NK; Verma MK; Anand R; Singh R; Vishwakarma RA; Hingorani L
ACS Omega; 2020 Nov; 5(43):27933-27943. PubMed ID: 33163776
[No Abstract] [Full Text] [Related]
6. Determination of withaferin A and withanolide A in mice plasma using high-performance liquid chromatography-tandem mass spectrometry: application to pharmacokinetics after oral administration of Withania somnifera aqueous extract.
Patil D; Gautam M; Mishra S; Karupothula S; Gairola S; Jadhav S; Pawar S; Patwardhan B
J Pharm Biomed Anal; 2013 Jun; 80():203-12. PubMed ID: 23584079
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and bioequivalence of
Kim SK; Venkatesan J; Rathi P; Antony B
Heliyon; 2023 Dec; 9(12):e22843. PubMed ID: 38144272
[TBL] [Abstract][Full Text] [Related]
8. Revisiting the Multifaceted Therapeutic Potential of Withaferin A (WA), a Novel Steroidal Lactone, W-ferinAmax Ashwagandha, from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
J Am Nutr Assoc; 2024 Feb; 43(2):115-130. PubMed ID: 37410676
[No Abstract] [Full Text] [Related]
9. Metabolite Profiling in Withania somnifera Roots Hydroalcoholic Extract Using LC/MS, GC/MS and NMR Spectroscopy.
Trivedi MK; Panda P; Sethi KK; Jana S
Chem Biodivers; 2017 Mar; 14(3):. PubMed ID: 27743505
[TBL] [Abstract][Full Text] [Related]
10. A critical assessment of the whole plant-based phytotherapeutics from
Kumar P; Banik SP; Goel A; Chakraborty S; Bagchi M; Bagchi D
Toxicol Mech Methods; 2023 Oct; 33(8):698-706. PubMed ID: 37533233
[No Abstract] [Full Text] [Related]
11. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
[TBL] [Abstract][Full Text] [Related]
12. Rational use of Ashwagandha in Ayurveda (Traditional Indian Medicine) for health and healing.
Joshi VK; Joshi A
J Ethnopharmacol; 2021 Aug; 276():114101. PubMed ID: 33831467
[TBL] [Abstract][Full Text] [Related]
13. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing nitric oxide generation.
Pathak P; Shukla P; Kanshana JS; Jagavelu K; Sangwan NS; Dwivedi AK; Dikshit M
J Ethnopharmacol; 2021 Oct; 278():114296. PubMed ID: 34090907
[TBL] [Abstract][Full Text] [Related]
14. In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells.
Kumar S; Seal CJ; Howes MJ; Kite GC; Okello EJ
Phytother Res; 2010 Oct; 24(10):1567-74. PubMed ID: 20680931
[TBL] [Abstract][Full Text] [Related]
15. Subcritical water extraction of withanosides and withanolides from ashwagandha (Withania somnifera L) and their biological activities.
Nile SH; Nile A; Gansukh E; Baskar V; Kai G
Food Chem Toxicol; 2019 Oct; 132():110659. PubMed ID: 31276745
[TBL] [Abstract][Full Text] [Related]
16. Review on anticancerous therapeutic potential of Withania somnifera (L.) Dunal.
Singh N; Yadav SS; Rao AS; Nandal A; Kumar S; Ganaie SA; Narasihman B
J Ethnopharmacol; 2021 Apr; 270():113704. PubMed ID: 33359918
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous estimation of five biomarkers of neuroprotective herb Ashwagandha NMITLI-118R AF1 in rat plasma and brain using LC-ESI-MS/MS: Application to its pharmacokinetic and stability studies.
Dadge SD; Tiwari N; Husain A; Verma S; Agarwal A; Garg R; Rath SK; Shanker K; Gayen JR
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123834. PubMed ID: 37481788
[TBL] [Abstract][Full Text] [Related]
18. Withanolide A is inherently de novo biosynthesized in roots of the medicinal plant Ashwagandha (Withania somnifera).
Sangwan RS; Das Chaurasiya N; Lal P; Misra L; Tuli R; Sangwan NS
Physiol Plant; 2008 Jun; 133(2):278-87. PubMed ID: 18312497
[TBL] [Abstract][Full Text] [Related]
19. Optimization of elicitation conditions with methyl jasmonate and salicylic acid to improve the productivity of withanolides in the adventitious root culture of Withania somnifera (L.) Dunal.
Sivanandhan G; Arun M; Mayavan S; Rajesh M; Jeyaraj M; Dev GK; Manickavasagam M; Selvaraj N; Ganapathi A
Appl Biochem Biotechnol; 2012 Oct; 168(3):681-96. PubMed ID: 22843063
[TBL] [Abstract][Full Text] [Related]
20. An updated review on phytochemistry and molecular targets of
Bashir A; Nabi M; Tabassum N; Afzal S; Ayoub M
Front Pharmacol; 2023; 14():1049334. PubMed ID: 37063285
[No Abstract] [Full Text] [Related]
[Next] [New Search]
